[1]秦亚东.多奈哌齐联合阿米替林治疗神经衰弱伴发认知障碍患者的临床效果[J].医学信息,2019,32(10):144-145,150.[doi:10.3969/j.issn.1006-1959.2019.10.047]
　QIN Ya-dong.Clinical Effect of Donepezil Combined with Amitriptyline in the Treatment of Patients with Neurasthenia and Cognitive Impairment[J].Journal of Medical Information,2019,32(10):144-145,150.[doi:10.3969/j.issn.1006-1959.2019.10.047]
点击复制

多奈哌齐联合阿米替林治疗神经衰弱伴发认知障碍患者的临床效果()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年10期
页码:
144-145,150
栏目:
药物与临床
出版日期:
2019-05-15

文章信息/Info

Title:
Clinical Effect of Donepezil Combined with Amitriptyline in the Treatment of Patients with Neurasthenia and Cognitive Impairment
文章编号:
1006-1959（2019）10-0144-03
作者:
秦亚东
（黑龙江省佳木斯市中心医院神经内科，黑龙江 佳木斯 154002）
Author(s):
QIN Ya-dong
(Department of Neurology,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China)
关键词:
多奈哌齐; 阿米替林; 神经衰弱; 认知障碍; 睡眠障碍
Keywords:
Donepezil; Amitriptyline; Neurasthenia; Cgnitive impairment; Sleep disorders
分类号:
R749.1
DOI:
10.3969/j.issn.1006-1959.2019.10.047
文献标志码:
A
摘要:
目的 分析多奈哌齐联合阿米替林治疗神经衰弱伴发认知障碍患者的临床效果。方法 选取2018年1月~12月我院收治的神经衰弱伴发认知障碍患者100例，随机分为对照组和研究组，各50例。对照组予以阿米替林治疗，研究组在对照组基础上加用多奈哌齐治疗，比较两组患者睡眠障碍、认知障碍、生活质量及不良反应发生情况。结果 研究组睡眠障碍、认知障碍评分低于对照组[（3.57±1.02）分vs（7.25±1.64）分，（3.61±0.93）分vs（7.13±1.55）分]，差异有统计学意义（P＜0.05）；研究组总发生率为6.00%，低于对照组的24.00%，差异有统计意义（P＜0.05）；研究组躯体功能、心理功能、物质生活、社会功能评分均高于对照组[（18.20±3.93）分vs（12.68±3.54）分，（18.59±3.62）分vs（13.77±3.32）分，（17.43±3.60）分vs（13.24±3.91）分，（17.89±3.62）分vs（12.53±3.78）分]，差异有统计意义（P＜0.05）。结论 多奈哌齐联合阿米替林治疗神经衰弱伴发认知障碍患者，可改善患者睡眠障碍、认知障碍，有效提高生活质量，减少患者不良反应的发生。
Abstract:
Objective To analyze the clinical effects of donepezil combined with amitriptyline in the treatment of patients with neurasthenia and cognitive impairment. Methods 100 patients with neurasthenia and cognitive impairment admitted to our hospital from January to December 2018 were randomly divided into control group and study group, 50 cases each. The control group was treated with amitriptyline. The study group was treated with donepezil on the basis of the control group. The sleep disorder, cognitive impairment, quality of life and adverse reactions were compared between the two groups. Results The scores of sleep disorder and cognitive impairment in the study group were lower than those in the control group [(3.57±1.02) points vs (7.25±1.64)points, (3.61±0.93) points vs (7.13±1.55) points], and the difference was statistically significant (P<0.05); the total incidence rate of the study group was 6.00%, which was lower than that of the control group 24.00%,the difference was statistically significant (P<0.05). The physical function, psychological function, material life and social function scores of the study group were higher than the control group[(18.20±3.93) points vs (12.68±3.54) points, (18.59±3.62) points vs (13.77±3.32) points, (17.43±3.60) points vs (13.24±3.91) points, (17.89±3.62) points vs (12.53 ± 3.78) points, the difference was statistically significant (P<0.05). Conclusion Donepezil combined with amitriptyline in the treatment of patients with neurasthenia and cognitive impairment can improve sleep disorders and cognitive impairment, improve quality of life and reduce adverse reactions.

参考文献/References:

[1]王桂荣,黄华.盐酸多奈哌齐联合西酞普兰治疗青中年脑梗死患者抑郁及认知功能障碍临床分析[J].中国实用神经疾病杂志,2018,21(10):1083-1087.
[2]徐瑞华.盐酸多奈哌齐治疗神经衰弱伴发认知障碍的临床效果分析[J].中外医学研究,2018,16(21):135-136.
[3]曹家驹,洪晓燕,冯上旭.多奈哌齐治疗神经衰弱伴发认知障碍的评价[J].药品评价,2016,13(20):42-44.
[4]王伟.盐酸多奈哌齐治疗神经衰弱伴发认知障碍的临床效果评价[J].中国药物与临床,2017,17(5):741-743.
[5]汤朝辉.阿米替林联合多奈哌齐对神经衰弱并发认知障碍患者进行治疗的效果研究[J].当代医药论丛,2017,15(8):25-26.
[6]马双喜,郑智慧,乔丰爽.阿米替林联合多奈哌齐治疗神经衰弱伴认知障碍患者的临床效果分析[J].河南医学研究,2016,25(4):697-698.
[7]袁堂坤.多奈哌齐在神经衰弱伴发认知障碍治疗中的应用分析[J].中国卫生标准管理,2015(9):257-258.
[8]吴福有.阿米替林联合多奈哌齐治疗神经衰弱伴认知障碍患者的临床效果分析[J].心理医生,2017,23(21):97-98.
[9]马俊霞.不同剂量多奈哌齐对轻中度老年痴呆患者认知功能的干预作用[J].中国实用神经疾病杂志,2016,19(23):51-53.
[10]潘早霞.多奈哌齐治疗神经衰弱伴发认知障碍的临床效果分析[J].中国社区医师,2016,32(13):89-90.
[11]周莎莎.盐酸多奈哌齐联合高压氧治疗脑卒中后血管性认知障碍的效果观察[J].中国实用神经疾病杂志,2016,19(19):63-64.
[12]沈雷.高压氧联合盐酸多奈哌齐治疗轻中度血管性认知障碍患者的疗效观察[J].中国药物经济学,2016,11(9):92-93.
[13]马立华.盐酸多奈哌齐片联合银杏叶片治疗老年血管性认知障碍分析[J].中国实用神经疾病杂志,2015,18(4):102-103.

相似文献/References:

[1]缪继东.盐酸吗啡缓释片联合低剂量阿米替林治疗中重度癌性骨痛的疗效观察[J].医学信息,2018,31(21):147.[doi:10.3969/j.issn.1006-1959.2018.21.042]
　MIAO Ji-dong.Effects of Morphine Hydrochloride Sustained-release Tablets Combined with Low Dose Amitriptyline in the Treatment of Moderate and Severe Cancer Bone Pain[J].Journal of Medical Information,2018,31(10):147.[doi:10.3969/j.issn.1006-1959.2018.21.042]
[2]张 辉,张 颖.多奈哌齐联合司来吉兰对阿尔茨海默病患者认知功能及不良反应的影响[J].医学信息,2022,35(13):110.[doi:10.3969/j.issn.1006-1959.2022.13.024]
　ZHANG Hui,ZHANG Ying.Effect of Donepezil Combined with Selegilan on Cognitive Function and Adverse Reactions in Patients with Alzheimer’s Disease[J].Journal of Medical Information,2022,35(10):110.[doi:10.3969/j.issn.1006-1959.2022.13.024]
[3]周建祥.多潘立酮联合阿米替林治疗功能性消化不良的疗效及其对胃动力学的影响[J].医学信息,2019,32(23):138.[doi:10.3969/j.issn.1006-1959.2019.23.041]
　ZHOU Jian-xiang.Efficacy of Domperidone Combined with Amitriptyline in the Treatment of Functional Dyspepsia and Its Effect on Gastric Dynamics[J].Journal of Medical Information,2019,32(10):138.[doi:10.3969/j.issn.1006-1959.2019.23.041]
[4]于京虎.复方脑肽节苷脂联合多奈哌齐对阿尔茨海默病患者认知功能及SOD水平的影响[J].医学信息,2023,36(03):148.[doi:10.3969/j.issn.1006-1959.2023.03.031]
　YU Jing-hu.Effect of Compound Porcine Cerebroside and Ganglioside Combined with Donepezil on Cognitive Function and SOD Level in Patients with Alzheimer’s Disease[J].Journal of Medical Information,2023,36(10):148.[doi:10.3969/j.issn.1006-1959.2023.03.031]
[5]孙 勇.多奈哌齐联合丁苯酞治疗血管性痴呆的临床疗效及对神经功能恢复的影响[J].医学信息,2023,36(23):77.[doi:10.3969/j.issn.1006-1959.2023.23.019]
　SUN Yong.Clinical Efficacy of Donepezil Combined with Butylphthalide in the Treatment of Vascular Dementia and its Effect on the Recovery of Neurological Function[J].Journal of Medical Information,2023,36(10):77.[doi:10.3969/j.issn.1006-1959.2023.23.019]

更新日期/Last Update: 2019-05-15